| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3332493 | HIV & AIDS Review | 2010 | 4 Pages |
Abstract
Participants preferred the FemCap, due to elimination of leakage and the single application, versus two applications with the vaginal applicator. The increased adherence and retention of gel over the cervix by using the FemCap may potentially increase the efficacy of Tenofovir.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Alfred A. Shihata, Steven A. Brody,